- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07937267
Cytological Assessment of Donor-Site Healing After Free Gingival Grafting
Cytological Evaluation of the Effects of Different Donor-Site Interventions on Healing After Free Gingival Graft Surgery
An adequate width of keratinized gingiva is important for maintaining periodontal and peri-implant tissue health. Free gingival grafting (FGG) is a commonly performed surgical procedure for increasing insufficient keratinized gingival width. This study aims to evaluate the effect of applying a chitosan sponge to the palatal donor site on wound healing after FGG using exfoliative cytology and to compare the findings with those obtained from a control group in which no chitosan sponge is applied.
At least 40 patients scheduled to undergo FGG because of insufficient keratinized gingival width will be included. The patients will be allocated to two groups: a test group and a control group. In the test group, a chitosan sponge will be applied to the palatal donor site, whereas no wound dressing will be applied to the palatal donor site in the control group. The primary outcome will be the keratinization index determined from cytological samples collected from the palatal donor site at one month after surgery. The keratinization index values at one month will be compared between the test and control groups.
All participants will receive detailed information about the study and the procedures, and written informed consent will be obtained. Clinical measurements will be recorded before surgery, after which the FGG procedure will be performed. Depending on group allocation, the palatal donor site will either be treated with a chitosan sponge or left without a wound dressing. Sutures will be removed on postoperative day 10.
For exfoliative cytological assessment, baseline samples will be collected from both the planned palatal donor site and the contralateral symmetrical healthy palatal site, which will not undergo surgery, in all patients. Samples collected from the symmetrical palatal site will serve as a reference for the baseline characteristics of healthy palatal mucosa. Follow-up samples will be collected exclusively from the palatal donor site on postoperative day 3,10 and at 1, 3, and 6 months. The keratinization index and other cellular features associated with wound healing will be assessed in the cytological samples. Findings obtained during the follow-up periods will be compared between the test group treated with a chitosan sponge and the control group in which no wound dressing is applied. In addition, the presence or absence of sensory loss at the palatal donor site will be evaluated using a periodontal probe.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Istanbul, Turkey (Türkiye)
- Recruiting
- Biruni University
-
Contact:
- Ayşe Ege Selman
- Phone Number: 902124448276
- Email: ayseegeselman@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Volunteering to participate in the study,
- Being at least 18 years of age,
- The need for SDG in patients with < 2 mm of keratinized gingiva on the vestibular side of the implant/tooth,
- No prior surgical procedures or grafts in the palatal region,Volunteering to participate in the study,
Exclusion Criteria:
- The presence of a systemic disease that would contraindicate surgical treatment,
- Uncontrolled diabetes (HbA1c > 7),
- Pregnancy or breastfeeding,
- Autoimmune and/or inflammatory diseases of the oral cavity,
- Active periodontal disease.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Control
|
Free gingival graft surgery |
|
Experimental: Test
|
Free gingival graft surgery Suturing of chitosan sponge to the palatal donor site |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Palatal donor site tissue thickness:
Time Frame: Pre-operative
|
The thickness of the donor site will be measured using an endodontic reamer. |
Pre-operative
|
|
Palatal donor site tissue thickness:
Time Frame: immediate Post-operative
|
The thickness of the donor site will be measured using an endodontic reamer. |
immediate Post-operative
|
|
Palatal donor site tissue thickness:
Time Frame: day 10
|
The thickness of the donor site will be measured using an endodontic reamer. |
day 10
|
|
Palatal donor site tissue thickness:
Time Frame: day 30
|
The thickness of the donor site will be measured using an endodontic reamer. |
day 30
|
|
Palatal donor site tissue thickness:
Time Frame: day 90
|
The thickness of the donor site will be measured using an endodontic reamer. |
day 90
|
|
Palatal donor site tissue thickness:
Time Frame: day 180
|
The thickness of the donor site will be measured using an endodontic reamer. |
day 180
|
|
Keratinization Index
Time Frame: day 3
|
Cells without nuclei / Total number of cells examined (n=200) × 100 |
day 3
|
|
Keratinization Index
Time Frame: day 10
|
Cells without nuclei / Total number of cells examined (n=200) × 100 |
day 10
|
|
Keratinization Index
Time Frame: day 30
|
Cells without nuclei / Total number of cells examined (n=200) × 100 |
day 30
|
|
Keratinization Index
Time Frame: day 90
|
Cells without nuclei / Total number of cells examined (n=200) × 100 |
day 90
|
|
Keratinization Index
Time Frame: day 180
|
Cells without nuclei / Total number of cells examined (n=200) × 100 |
day 180
|
|
Superficial cell index
Time Frame: day 3
|
Total number of cells with and without pyknotic nuclei / Total number of cells examined (n=200) × 100 |
day 3
|
|
Superficial cell index
Time Frame: day 10
|
Total number of cells with and without pyknotic nuclei / Total number of cells examined (n=200) × 100 |
day 10
|
|
Superficial cell index
Time Frame: day 30
|
Total number of cells with and without pyknotic nuclei / Total number of cells examined (n=200) × 100 |
day 30
|
|
Superficial cell index
Time Frame: day 90
|
Total number of cells with and without pyknotic nuclei / Total number of cells examined (n=200) × 100 |
day 90
|
|
Superficial cell index
Time Frame: day 180
|
Total number of cells with and without pyknotic nuclei / Total number of cells examined (n=200) × 100 |
day 180
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Loss of sensation
Time Frame: Day 10
|
To test it objectively, two different movements will be performed with the tip of the probe: immersion and scraping. |
Day 10
|
|
Loss of sensation
Time Frame: Day 30
|
To test it objectively, two different movements will be performed with the tip of the probe: immersion and scraping. |
Day 30
|
|
Loss of sensation
Time Frame: Day 90
|
To test it objectively, two different movements will be performed with the tip of the probe: immersion and scraping. |
Day 90
|
|
Loss of sensation
Time Frame: Day 180
|
To test it objectively, two different movements will be performed with the tip of the probe: immersion and scraping. |
Day 180
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2015-KAEK-80-23-44
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.